In November last year, Sweden and Singapore signed a memorandum of understanding (MoU) on cooperation in health innovation.
Now, a delegation organized by Swecare, BusinessSweden, SwedenBIO and Vinnova and consisting of Swedish biotech and medtech companies is heading to Singapore. The delegation will be in Sinapore from September 8–10, 2025 to strengthen ties with Singapore’s dynamic life science and health ecosystem.
The delegation offers interesting opportunitied for both biotech- and medtech companies. For biotech companies, the program offers valuable insights into Singapore’s life science landscape, opportunities to engage with key stakeholders, including investors, and participation in the ASIA BIO Partnering Forum.
For medtech companies, the agenda includes targeted meetings with leading actors within Singapore’s healthcare system, both from the public and private sectors, as well as opportunities to explore strategic partnerships.
Adler Therapeutics, HealthCap, IONLACE, Invest in Skåne, Medclair, Medicon Village, Prolevi Bio, Rud Pedersen Group, Sprint Bioscience, Cymsel and Salipro Biotech are confirmed companies joining the delegation.
